PharmaTimes | Industry News | World News | PhRMA firms’ “record 313 mental illness drugs now in R&D” "A record 313 new medicines to treat mental health disorders are now being developed by US pharmaceutical and biotechnology companies, says a new industry report.
All 313 new products are either in clinical trials or awaiting review by the Food and Drug Administration (FDA), according to the study, which is produced by the Pharmaceutical Research and Manufacturers of America (PhRMA).
- Sent using Google Toolbar"
No comments:
Post a Comment